Hepatitis C vaccine trial for healthy adults
Part of Digestive system, Infections clinical trials.
This trial tests a new protein-based vaccine to prevent hepatitis C. It is for healthy, non-smoking adults aged 18-45 who are up to date on their flu and COVID-19 vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are in good general health and a non-smoker
- You have not had hepatitis C or tested positive for it before
- You are willing to stay in Canada for the next year and avoid traveling outside the country for 2 weeks after each vaccine dose
- You are up to date on your seasonal flu and COVID-19 vaccines
- You agree not to donate blood or join other trials during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.
This trial tests a home-use test for hepatitis C (HCV) to see if people can use it correctly without help. It is for adults who are not healthcare workers or in other studies.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
This study tests a hepatitis E vaccine called Hecolin in healthy people (ages 2–45) and in adults (18–45) living with HIV who are on antiviral treatment. It aims to see how well the vaccine works and if it's safe for different groups.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.